MorphoSys

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Map view:

Zoom: 100%

More settings

Connection length 100% Label size 100% Node size 100% Line width 100% Label width 100%

Export map as:

MorphoSys topic overview

The analysis highlights Technology, History, Art and Companies as prominent areas in the source structure around MorphoSys.

Related topics: 43
Source areas: 4
Connected nodes: 47
Extracted relationships: 44
Concept neighborhoods: 17
Bridge connections: 47

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

History · 23 topics

Overview · 12 topics

Pipeline · 7 topics

Technology · 1 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

Founded: 1992; 34 years ago (1992)
Industry: Biotechnology
Headquarters: Planegg, Upper Bavaria, Germany
Key people: Dr. Jean-Paul Kress (CEO) Sung Lee (CFO) Dr. Malte Peters (Chief Research & Development Officer) Dr. Roland Wandeler (CCO) Dr. Marc Cluzel (chairman of Supervisory Board)
Net income: €97.9 million (2020)
Number of employees: 615 (end 2020)

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How MorphoSys connects Entity context

The extracted context around MorphoSys shows recurring relationship patterns in the source. For example, MorphoSys → Additional, Bayer, Centocor, Frankfurt Stock Exchange, In, Janssen Biotech, MOR, Novartis, Pfizer, Roche, Schering AG, The Another extracted example is MorphoSys → As, B-cell, CD19, December, MOR208, Tafasitamab, Two. Use these groups to spot repeated connection types before inspecting the individual relationships.

Top relations

related to history · 12

MorphoSys → Additional, Bayer, Centocor, Frankfurt Stock Exchange, In, Janssen Biotech, MOR, Novartis, Pfizer, Roche, Schering AG, The

related to Pipeline · 7

MorphoSys → As, B-cell, CD19, December, MOR208, Tafasitamab, Two

related to Technology · 5

MorphoSys → Another, HuCAL, Human Combinatorial Antibody Library, Its, OkapY

related to External links · 4

MorphoSys → I-Mab BiopharmaLanthio Pharma, Official, US Inc, Xencor Inc

Traded as · 2

MorphoSys → FWB: MOR, Nasdaq: MOR

Founded · 1

MorphoSys → 1992; 34 years ago (1992)

Headquarters · 1

MorphoSys → Planegg, Upper Bavaria, Germany

Industry · 1

MorphoSys → Biotechnology

Key people · 1

MorphoSys → Dr. Jean-Paul Kress (CEO) Sung Lee (CFO) Dr. Malte Peters (Chief Research & Development Officer) Dr. Roland Wandeler (CCO) Dr. Marc Cluzel (chairman of Supervisory Board)

Net income · 1

MorphoSys → €97.9 million (2020)

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

company development antibody clinical us novartis tafasitamab 2020 ag inc developed proprietary dr pipeline nasdaq otilimab license agreement treatment drug

MorphoSys relationships Subject–Predicate–Object triples

TTTA extracted 44 structured relationships around MorphoSys. Examples in this analysis include MorphoSys → Founded → 1992; 34 years ago (1992) and MorphoSys → Headquarters → Planegg, Upper Bavaria, Germany. The table shows each extracted connection, where it came from and its confidence.

Subject	Predicate	Object	Confidence	Src
MorphoSys	Founded	1992; 34 years ago (1992)	1.00	infobox
MorphoSys	Headquarters	Planegg, Upper Bavaria, Germany	1.00	infobox
MorphoSys	Industry	Biotechnology	1.00	infobox
MorphoSys	Key people	Dr. Jean-Paul Kress (CEO) Sung Lee (CFO) Dr. Malte Peters (Chief Research & Development Officer) Dr. Roland Wandeler (CCO) Dr. Marc Cluzel (chairman of Supervisory Board)	1.00	infobox
MorphoSys	Net income	€97.9 million (2020)	1.00	infobox
MorphoSys	Number of employees	615 (end 2020)	1.00	infobox
MorphoSys	Operating income	€27.4 million (2020)	1.00	infobox
MorphoSys	Parent	Novartis	1.00	infobox
MorphoSys	Products	Immunotherapy	1.00	infobox
MorphoSys	Revenue	€327.7 million (2020)	1.00	infobox
MorphoSys	Total assets	€1,659.5 million (end 2020)	1.00	infobox
MorphoSys	Total equity	€621.3 million (end 2020)	1.00	infobox
MorphoSys	Traded as	FWB: MOR	1.00	infobox
MorphoSys	Traded as	Nasdaq: MOR	1.00	infobox
MorphoSys	Type	Public	1.00	infobox
MorphoSys	Website	morphosys.com	1.00	infobox

Related concept clusters Concept neighborhoods

The concept neighborhoods around MorphoSys bring nearby vocabulary together. In this analysis, examples include Us, Development and Announced. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

MorphoSys
- Us
- Development
- Announced
- Exchange
- Stock
- Agreement
- Developed
- Inc
- License
- Novartis
- Frankfurt
- Nasdaq
morphosys
- Us
- Development
- Announced
- Exchange
- Stock
- Agreement
- Developed
- Inc
- License
- Novartis
- Frankfurt
- Nasdaq
clinical trial
- Development
- Tafasitamab
- Now
- Otilimab
- Treatment
- Company
- Drugs
- Glaxosmithkline
- Pharma
- Announced
- Drug
- Proprietary
antibody
- Proprietary
- Development
- Technology
- Drug
- Otilimab
- Treatment
- Clinical
- Now
- Developed
- Inc
- Tafasitamab
- Us
schering ag
- Founded
- Nasdaq
- Germany
- Biotech
- Frankfurt
- Pipeline
- Technology
- Dr
- Exchange
- Now
- Stock
- Morphosys
frankfurt stock exchange
- Stock
- Exchange
- Frankfurt
- Nasdaq
- Us
- Morphosys
- Announced
- Subsidiary
- Novartis
- Inc
janssen biotech
- Developed
- Diseases
- Pharma
- Pipeline
- Subsidiary
- Approved
- Now
- Proprietary
- Treatment
- Morphosys
germany
- Nasdaq
- Pipeline
- Subsidiary
- Technology
- Dr
- Inc
- Us
- Morphosys

Connections between topic areas Semantic bridges

For MorphoSys, one of the stronger structural bridges in this analysis connects MorphoSys with History. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3

MorphoSys — History · splits 24 ⟂ 24

MorphoSys — Overview · splits 35 ⟂ 13

MorphoSys — Pipeline · splits 40 ⟂ 8

Map overview Semantic statistics

MorphoSys

Nodes48

Edges47

Triples44

Avg. degree1.96

Density0.041667

Components1

Source & methodology

TTTA analyzes the structure around MorphoSys to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Technology, History, Art & Companies, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — MorphoSys · EN edition · Analysis: TopicsToTalkAbout